Shopping Cart
- Remove All
- Your shopping cart is currently empty
SB-215505 is a subtype-selective 5-HT2B receptor antagonist that inhibits 5-HT2B, 5-HT2A, and 5-HT2C.SB-215505 can be used to study prostate cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $228 | In Stock | |
5 mg | $569 | In Stock | |
10 mg | $793 | In Stock | |
25 mg | $1,180 | In Stock | |
50 mg | $1,630 | In Stock |
Description | SB-215505 is a subtype-selective 5-HT2B receptor antagonist that inhibits 5-HT2B, 5-HT2A, and 5-HT2C.SB-215505 can be used to study prostate cancer. |
Targets&IC50 | 5-HT2B Receptor:8.3 (pKi), 5-HT2C Receptor:7.66 (pKi), 5-HT2A Receptor:6.77 (pKi) |
In vivo | In male Sprague-Dawley rats weighing 230-260 g, SB-215505 (0.1, 0.3, and 1.0 mg/kg; intraperitoneal injection; two doses) dose-dependently increased wakefulness (W) and decreased intermediate stage of sleep (IS), paradoxical sleep (PS), and slow-wave sleep stage 2 (SWS-2)[2]. |
Alias | SB215505, SB 215505 |
Molecular Weight | 337.8 |
Formula | C19H16ClN3O |
Cas No. | 162100-15-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.